These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19175194)

  • 1. The use of ACE inhibitors and ARBs in severe chronic kidney disease: point-counterpoint.
    Creamer LM; Ryan J
    CANNT J; 2008; 18(4):46-8. PubMed ID: 19175194
    [No Abstract]   [Full Text] [Related]  

  • 2. Complementary effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in slowing the progression of chronic kidney disease.
    Ripley E
    Am Heart J; 2009 Jun; 157(6 Suppl):S7-S16. PubMed ID: 19450722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing ACE-inhibitor therapy for chronic kidney disease.
    Hebert LA
    N Engl J Med; 2006 Jan; 354(2):189-91. PubMed ID: 16407515
    [No Abstract]   [Full Text] [Related]  

  • 4. Stage IV chronic kidney disease.
    Hirsch S
    N Engl J Med; 2010 May; 362(20):1942-3; author reply 1943. PubMed ID: 20496469
    [No Abstract]   [Full Text] [Related]  

  • 5. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system.
    Palmer BF
    N Engl J Med; 2004 Aug; 351(6):585-92. PubMed ID: 15295051
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety of ACE inhibitor therapies in patients with chronic kidney disease.
    Sidorenkov G; Navis G
    Expert Opin Drug Saf; 2014 Oct; 13(10):1383-95. PubMed ID: 25148900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure medications: ACE-I/ARB and chronic kidney disease.
    Han H
    J Ren Nutr; 2013 Nov; 23(6):e105-7. PubMed ID: 24209897
    [No Abstract]   [Full Text] [Related]  

  • 8. ACE inhibitors and ARBs: Managing potassium and renal function.
    Momoniat T; Ilyas D; Bhandari S
    Cleve Clin J Med; 2019 Sep; 86(9):601-607. PubMed ID: 31498767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, or both in chronic heart failure.
    Young JB
    Heart Fail Clin; 2005 Apr; 1(1):39-47. PubMed ID: 17386832
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperkalemia risk and treatment of heart failure.
    Segura J; Ruilope LM
    Heart Fail Clin; 2008 Oct; 4(4):455-64. PubMed ID: 18760757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nephrology 2007].
    Hugo C
    Dtsch Med Wochenschr; 2007 Jun; 132(25-26):1373-5. PubMed ID: 17570083
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug therapy in the secondary prevention of atherosclerosis].
    Kettunen R
    Duodecim; 2002; 118(20):2093-101. PubMed ID: 12463000
    [No Abstract]   [Full Text] [Related]  

  • 13. Are renin-angiotensin-aldosterone system blockers distinguishable based on cardiovascular and renal outcomes in nephropathy?
    Kalaitzidis R; Bakris G
    Postgrad Med; 2009 Mar; 121(2):77-88. PubMed ID: 19332965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin-angiotensin system inhibitors in proteinuric chronic kidney disease.
    Hirsch S
    Compr Ther; 2009; 35(2):91-5. PubMed ID: 19618757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malignant arrhythmias caused by hyperkalemia: a new area of drug-induced electrolyte abnormalities].
    Tomcsányi J; Somlói M; Arabadzisz H; Horváth L
    Orv Hetil; 2002 Mar; 143(13):663-6. PubMed ID: 11975043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the renin-angiotensin-aldosterone system to prevent ischemic and atherothrombotic events.
    Papademetriou V
    Am Heart J; 2009 Jun; 157(6 Suppl):S24-30. PubMed ID: 19450721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does concurrent renin-angiotensin-aldosterone blockade in (older) chronic kidney disease patients play a role in the acute renal failure epidemic in US hospitalized patients?--Three cases of severe acute renal failure encountered in a northwestern Wisconsin Nephrology practice.
    Onuigbo MA
    Hemodial Int; 2009 Oct; 13 Suppl 1():S24-9. PubMed ID: 19775421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nephrology 2005/2006. Recent clinical studies and developments in science].
    Floege J
    Dtsch Med Wochenschr; 2006 Jun; 131(25-26):1445-8. PubMed ID: 16794972
    [No Abstract]   [Full Text] [Related]  

  • 20. Benazepril for advanced chronic renal insufficiency.
    Bloom JM
    N Engl J Med; 2006 Apr; 354(14):1530-1; author reply 1530-1. PubMed ID: 16598052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.